Which are the symptoms of Pyruvate Kinase Deficiency?

Pyruvate Kinase Deficiency is a rare hereditary metabolic disorder characterized primarily by chronic hemolytic anemia, where red blood cells are destroyed faster than they can be replaced. Symptoms vary significantly among individuals, ranging from mild, compensated anemia to severe, transfusion-dependent disease, often manifesting as fatigue, jaundice, and gallstones.

What are the primary symptoms of Pyruvate Kinase Deficiency?

The clinical presentation of Pyruvate Kinase Deficiency is driven by the premature destruction of red blood cells (hemolysis). Common symptoms include:

• Chronic Fatigue: Often due to persistent anemia, leading to low energy levels.


• Jaundice: A yellowing of the skin and eyes caused by elevated bilirubin levels from broken-down red blood cells.


• Splenomegaly: An enlarged spleen, which occurs as the organ works harder to filter damaged red blood cells.


• Gallstones: Increased bilirubin can lead to the formation of pigment gallstones, even in children.


• Pale skin (pallor): A direct result of decreased hemoglobin levels.

How does symptom severity vary in Pyruvate Kinase Deficiency?

The severity of Pyruvate Kinase Deficiency is highly heterogeneous. Some patients are diagnosed shortly after birth with severe neonatal jaundice requiring exchange transfusions, while others may remain asymptomatic until adulthood. Factors such as the specific genetic mutation and the body's ability to compensate for hemolysis determine the clinical course of Pyruvate Kinase Deficiency.

When should you seek immediate medical attention?

Patients with Pyruvate Kinase Deficiency should seek urgent care if they experience a "hemolytic crisis." This is characterized by a sudden increase in the rate of red blood cell destruction, often triggered by infections. Watch for rapidly worsening jaundice, dark-colored urine (cola-colored), severe abdominal pain, or extreme lethargy. Because Pyruvate Kinase Deficiency can lead to iron overload, especially in those who receive frequent blood transfusions, monitoring iron levels is critical to prevent organ damage.

How do symptoms change over time?

While the underlying genetic defect in Pyruvate Kinase Deficiency remains constant, symptoms may fluctuate. Over time, chronic hemolysis can lead to secondary complications such as iron overload, bone density loss, and pulmonary hypertension. Regular monitoring by a hematologist is essential to manage the lifelong progression of Pyruvate Kinase Deficiency.

Next steps

• Consult with a hematologist who specializes in rare hemolytic anemias.


• Join our community at DiseaseMaps.org to connect with other patients and families navigating this condition.


• Maintain a detailed log of your hemoglobin levels and transfusion history.


• Discuss regular iron-status monitoring with your care team.

Medical disclaimer: This content is for informational purposes only and does not constitute medical advice; always consult with a qualified healthcare professional regarding your specific health needs.

References

• NIH Genetic and Rare Diseases (GARD) Information Center: Pyruvate Kinase Deficiency.


• Orphanet: Pyruvate Kinase Deficiency (ORPHA:773).


• OMIM (Online Mendelian Inheritance in Man): Entry #266200.


• Pyruvate Kinase Deficiency Foundation: Patient-focused clinical resources.